Table 1 Potency assay of the untreated and trypsin-treated AAV2 capsids.
From: Adeno-associated virus serotype 2 capsids with proteolytic cuts by trypsin remain intact and potent
% Relative potency | ||||
|---|---|---|---|---|
Plate | Untreated assay control | Trypsin-treated | ||
10 min | 30 min | 60 min | ||
1 | 79.9% | 110.8% | 118.8% | 116.0% |
2 | 91.7% | 105.4% | 106.4% | 126.9% |
3 | 94.4% | 105.7% | 129.3% | 139.5% |
mean | 88.7% | 107.3% | 118.2% | 127.5% |
%CV | 7.1 | 2.3 | 7.9 | 7.5 |
